HemoShear Therapeutics Enters into Rare Liver Disease Research Collaboration with Takeda
AgroSpheres Announces Strategic Alliance with Orion Integrated Biosciences
TearSolutions, Inc. Announces Results from Phase I/II trial of LacripepTM to Treat Primary Sjögren’s Syndrome and Appoints Anil Asrani President and CEO
HemoShear Therapeutics Receives FDA Clearance of IND for Phase 2 Study of its Investigational Drug HST5040 for the Treatment of Methylmalonic Acidemia and Propionic Acidemia